Silence Therapeutics plc
NASDAQ:SLNBiotechnology
Healthcare
$19.80 +2.81%
+$0.19 today
- Market cap
- $935.23M
- Beta
- 1.48
- P/E (TTM)
- -3.9
- EPS (TTM)
- -$1.80
52W Low $4.19High $8.40
Volume 1.21M
Average 0.31M
Price history
Silence Therapeutics plc SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+193.33%
Period high
$19.83
Period low
$4.30
Latest
$19.80
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 13, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| DEFA14A | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G/A | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G | Nov 5, 2026 | Nov 5, 2026 | |
| DEFA14A | Oct 19, 2026 | Oct 19, 2026 | |
| DEFA14A | Oct 19, 2026 | Oct 19, 2026 | |
| 8-K | Oct 19, 2026 | Oct 19, 2026 | |
| SC 13G | Oct 13, 2026 | Oct 13, 2026 | |
| SC 13G/A | Oct 13, 2026 | Oct 13, 2026 | |
| SC 13D/A | Aug 13, 2026 | Aug 13, 2026 | |
| 4 | Aug 13, 2026 | Aug 13, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| 424B5 | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 12, 2026 | Aug 12, 2026 |
Competitors
Who does Silence Therapeutics plc compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about SLN's filings, answered from its disclosures.
What is the latest SLN filing?
The latest filing shown is 10-Q dated Nov 13, 2026.
How many recent filings does SLN have?
Intrinsic Alpha currently shows 20 recent filings for SLN.
Continue the stock analysis
Jump to another research area for this company.